首页|期刊导航|海南医科大学学报|基于网络药理学和16S rRNA测序探讨黄连解毒汤治疗2型糖尿病的作用机制

基于网络药理学和16S rRNA测序探讨黄连解毒汤治疗2型糖尿病的作用机制OA

The mechanism of action of Huanglian Jiedu Decoction in the treatment of type 2 diabetes mellitus was studied based on network pharmacology and 16S rRNA sequencing

中文摘要英文摘要

目的:通过网络药理学和16S rRNA测序方法研究黄连解毒汤治疗2型糖尿病的作用机制.方法:在中药系统药理学数据库与分析平台(TCMSP)筛选黄连解毒汤的活性成分及靶点,将所获得靶点导入蛋白质数据库(UniProt)查找对应基因名;在人类基因组数据库(GeneCards)、在线人类孟德尔遗传数据库(OMIM)、TTD数据库收集疾病靶点;通过韦恩图得到药物和疾病的交集靶点,并利用Cytoscape 3.7.2软件构建"药物成分-疾病靶点"网络以确定关键活性成分;通过STRING数据库进行蛋白与蛋白相互作用(PPI)分析,利用Cytoscape 3.7.2软件中插件功能筛选关键靶点;然后通过Metascape数据库进行KEGG富集分析并构建"药物成分-疾病靶点-信号通路"网络以确定关键信号通路;最后通过H&E染色和16S rRNA测序方法对网络药理学结果进行实验验证.结果:通过网络药理学方法分析,得到黄连解毒汤共有85种活性成分及对应靶点236个,疾病靶点1 549个;两者交集靶点133个,所对应活性成分62个;黄连解毒汤的关键活性成分为槲皮素、汉黄芩素等,PPI网络分析主要包括蛋白激酶B1(AKT1)、肿瘤坏死因子(TNF)、白细胞介素-6(IL-6)等核心靶点且与磷酸肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路密切相关.通过动物实验发现,与正常组相比,模型组大鼠结肠组织结构异常,腺体萎缩且排列紊乱,部分腺体间距增宽,杯状细胞明显减少;黄连解毒汤干预后结肠组织结构明显改善,腺体排列整齐,可见大量杯状细胞.并且黄连解毒汤能够影响肠道菌群丰富度和多样性,在门水平上增加厚壁菌门(Firmicutes)丰度,降低拟杆菌门(Bacteroidetes)丰度,在属水平上增加乳酸杆菌属(Lactobacillus)、异芽孢杆菌属(Allobaculum)和布劳特氏菌属(Blautia)等有益菌丰度;LEfSe分析发现异芽孢杆菌属(Allobaculum)、乳酸球菌属(Lactococcus)和布劳特氏菌属(Blautia)是黄连解毒汤治疗2型糖尿病的差异性标志物.结论:黄连解毒汤能够促进有益菌增殖,减轻肠道炎症反应,修复肠屏障来治疗2型糖尿病.

Objective:To investigate the mechanism of action of Huanglian Jiedu Decoction in the treatment of type 2 diabetes mellitus by network pharmacology and 16S rRNA sequencing methods.Methods:The active ingredients and targets of Huanglian Jiedu Decoction were screened in the TCM Systematic Pharmacology Database and Analysis Platform(TCMSP),and the ob-tained targets were imported into the protein database(UniProt)to find the corresponding gene names.Disease targets were col-lected in the human genome database(GeneCards),the online human Mendelian genetic database(OMIM),and the TTD data-base.The intersection targets of drugs and diseases were obtained through the Venn diagram,and the"drug ingredient-disease tar-get"network was constructed by using Cytoscape 3.7.2 software to determine the key active ingredients.Protein-protein interaction(PPI)analysis was performed through the STRING database,and key targets were screened using the plug-in function in Cyto-scape 3.7.2 software.Then,the KEGG enrichment analysis was carried out through the Metascape database,and the"drug component-disease target-signaling pathway"network was constructed to identify the key signaling pathways.Finally,the network pharmacology results were verified by H&E staining and 16S rRNA sequencing.Results:A total of 85 active ingredients and 236 corresponding targets were found in Huanglian Jiedu Decoction,and 1 549 disease targets were found by network pharmacology analysis.There were 133 intersecting targets and 62 corresponding active ingredients.The key active ingredients in Huanglian Jie-du Decoction are quercetin and wogonin,etc.The core targets of the PPI network analysis were protein kinase 1(AKT1),tumor necrosis factor(TNF),interleukin-6(IL-6),and phosphoinositide 3-kinase/protein kinase B(PI3K/Akt)signaling pathways are closely related.Through animal experiments,it was found that compared to the normal group,the colon tissue structure of the rats in the model group was abnormal,the glands were atrophied and disordered,the spacing between some glands was widened,and the goblet cells were significantly reduced.After the intervention of Huanglian Jiedu Decoction,the tissue structure of the co-lon was significantly improved,the glands were arranged neatly,and a large number of goblet cells could be seen.In addition,Huanglian Jiedu Decoction could affect the richness and diversity of intestinal microbiota,increasing the abundance of Firmicutes at the phylum level,decreasing the abundance of Bacteroides,and increasing the abundance of beneficial bacteria such as Lactoba-cillus,Allobaculum and Blautia at the genus level.LEfSe analysis showed that Allobaculum,Lactococcus and Blautia were dif-ferential markers in the treatment of type 2 diabetes mellitus by Huanglian Jiedu Decoction.Conclusion:Huanglian Jiedu Decoc-tion can promote the proliferation of beneficial bacteria,reduce intestinal inflammation,and repair the intestinal barrier to treat type 2 diabetes.

韩雪;唐秋梅;王巍;杨光勇;田维毅;何光志

贵州中医药大学,贵州 贵阳 550025||德江县人民医院内分泌科,贵州 德江 565200贵州中医药大学,贵州 贵阳 550025贵州中医药大学,贵州 贵阳 550025贵州中医药大学,贵州 贵阳 550025贵州中医药大学,贵州 贵阳 550025贵州中医药大学,贵州 贵阳 550025

医药卫生

黄连解毒汤2型糖尿病网络药理学16S rRNA测序

Huanglian Jiedu DecoctionType 2 diabetes mellitusNetwork pharmacology16S rRNA

《海南医科大学学报》 2026 (12)

936-946,11

This study was supported by the National Natural Science Foundation of China(82060796)Guizhou Provincial Science and Technology Foundation Project[Qiankehe Foundation(2020)1Y392]Guizhou Provincial Administration of Traditional Chinese Medicine Science and Technology Research Project for Traditional Chinese Medicine and Ethnic Medicine(QZYY-2022-005)Guizhou Provincial Science and Technology Innovation Talent Team Construction Project[Qiankehe Platform Talent(2020)5010]Guizhou Provincial Development and Reform Commission Engineering Research Center Construction Project[Qian Development and Reform High-Tech(2020)No.896]Guizhou Science and Technology Plan Project[Qiankehe Support(2020)4Y187] 国家自然科学基金(82060796)贵州省科技科学技术基金[黔科合基础(2020)1Y392]贵州省中医药管理局中医药、民族医药科学技术研究课题(QZYY-2022-005)贵州省科技创新人才团队[黔科合平台人才(2020)5010]贵州省发改委工程研究中心建设项目[黔发改高技(2020)896号]贵州省科技计划项目[黔科合支撑(2020)4Y187号]

10.13210/j.cnki.jhmu.20250314.004

评论